Related Experiment Video

Updated: Sep 13, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.9K

Chronic Hepatitis C Infection: Is Elimination a Myth or in Our Midst?

Sherilyn Camille Brinkley1

  • 1Johns Hopkins University, Division of Infectious Diseases, 725 North Wolfe Street, Fisher Center 218, Baltimore, MD 21205, USA.

The Nursing Clinics of North America
|July 27, 2025
PubMed

Insights

Hepatitis C (HCV) is increasing in young adults, yet many remain undiagnosed or untreated due to significant barriers. Overcoming these obstacles is crucial for HCV elimination efforts.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern, leading to chronic liver disease.
  • HCV prevalence is rising among young adults in the United States, posing a growing public health challenge.
  • Despite effective treatments, diagnosis and care initiation rates remain suboptimal.

Purpose of the Study:

  • To highlight the current challenges in the Hepatitis C care continuum.
  • To emphasize the need for comprehensive strategies to improve HCV diagnosis and treatment.
  • To underscore the importance of addressing barriers for HCV elimination.

Main Methods:

  • This abstract summarizes the current state of Hepatitis C care.
  • It reviews patient, provider, and systemic factors affecting treatment access.
  • It discusses the implications for public health policy and intervention.

Main Results:

  • A substantial proportion of individuals with HCV remain undiagnosed.
  • Less than one-third of diagnosed individuals receive timely treatment.
  • Multiple barriers impede progress along the HCV care continuum.

Conclusions:

  • Effective treatments for Hepatitis C are available but underutilized.
  • Addressing multifaceted barriers is essential for improving patient outcomes.
  • A well-funded, multi-pronged approach is necessary to achieve HCV elimination goals.

Keywords:
Barriers to careChronic hepatitis CDirect acting antiviralsElimination plansSimplified treatment

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.3K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.3K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.9K
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.5K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
162
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
226
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
128